Results 71 to 80 of about 1,492,137 (202)

A Prospective Study of Individuals at Risk of Multiple Sclerosis Informs the Design of Primary Prevention Studies

Annals of Clinical and Translational Neurology, Volume 13, Issue 8, Page 1591-1601, August 2026.
ABSTRACT Objective In multiple sclerosis, the optimal time for deploying a therapeutic intervention is before the central nervous system is damaged; given the success of trials treating the earliest stage of MS, the radiologically isolated syndrome, developing primary prevention strategies is an important next challenge.
Amy W. Laitinen, Ceren Tozlu, Tina Roostaei, Fatoumata Diallo, Kaho Onomichi, Jiyeon Son, Zongqi Xia, Philip L. De Jager   +7 more
wiley   +1 more source

Persistence of antibodies, boostability, and interchangeability of Japanese encephalitis vaccines: A systematic review and dose-response meta-analysis

, 2022
BackgroundThe burden of Japanese encephalitis (JE) is substantial and is arguably one of the most serious viral encephalitic diseases with high case fatality and no specific treatment.
Devine, Gregor J, Mills, Deborah J., Hugo, Leon E, Thalib, Lukman, Furuya-Kanamori, Luis, Clark, Justin, Mills, Deborah J, Gyawali, Narayan, Nazmul, Islam, Hugo, Leon E., Xu, Chang, Lau, Colleen L., Devine, Gregor J., Lau, Colleen L, Islam, Nazmul   +14 more
core   +1 more source

Identification and isolation of Genotype-I Japanese Encephalitis virus from encephalitis patients

Virology Journal, 2010
Historically, Japanese Encephalitis virus (JEV) genotype III (GIII) has been responsible for human diseases. In recent years, JEV genotype I (GI) has been isolated from mosquitoes collected in numerous countries, but has not been isolated from patients ...
Gao Xiaoyan, Jiang Hongyue, Chen Weixin, Lv Zhi, Li Minghua, Zhai Yougang, Yuan Jun, Yu Deshan, Deng Zhang, Ye Xufang, Zhang Hailin, Fu Shihong, Wang Lihua, Cao Yuxi, Wang Huanyu, Tang Qing, Liang Guodong   +16 more
doaj   +1 more source

Active Vaccination Strategies for Alzheimer's Disease: An Expanded Review

European Journal of Immunology, Volume 56, Issue 8, August 2026.
Overview of immunotherapeutic strategies targeting Alzheimer's disease (AD) pathology and their clinical implications. (Left) Key neuropathological hallmarks of AD, including extracellular amyloid‐beta (Aβ) aggregates and intraneuronal hyperphosphorylated Tau (phospho‐Tau), converge to produce synaptic failure, neuroinflammation and neuronal ...
Antonella Comitato, Antonino Neri, Andrea Cossarizza   +2 more
wiley   +1 more source

Anti-Flavivirus Vaccines: Review of the Present Situation and Perspectives of Subunit Vaccines Produced in Escherichia coli

Vaccines, 2020
This article aims to review the present status of anti-flavivirus subunit vaccines, both those at the experimental stage and those already available for clinical use.
Sergio C. Araujo, Lennon R. Pereira, Rubens P. S. Alves, Robert Andreata-Santos, Alex I. Kanno, Luis Carlos S. Ferreira, Viviane M. Gonçalves   +6 more
doaj   +1 more source

Japanese Encephalitis Vaccine : Recommendations of the Advisory Committee on Immunization Practices [PDF]

This report updates the 2010 recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) regarding prevention of Japanese encephalitis (JE) among U.S.

core   +1 more source

Human Parvovirus 4 as Potential Cause of Encephalitis in Children, India [PDF]

, 2011
To investigate whether uncharacterized infectious agents were associated with neurologic disease, we analyzed cerebrospinal fluid specimens from 12 children with acute central nervous system infection.
Vasanthapuram, R., Laura Benjamin, Lewthwaite, P., Ravi Vasanthapuram, Vasanthapuram, Ravi, Colin P. Sharp, Simmonds, Peter, David Wang, Peter Simmonds, Lewthwaite, Penny, Zhao, G., Tom Solomon, Guoyan Zhao, Sharp, C., Benjamin, Laura A, Sharp, Colin, Solomon, T., Benjamin, L.A., Zhao, Guoyan, Penny Lewthwaite, Wang, D., Laura A. Benjamin, Wang, David, Simmonds, P., Solomon, Tom   +24 more
core   +1 more source

Advancements in nanoparticle-based vaccine development against Japanese encephalitis virus: a systematic review

Frontiers in Immunology
Vaccination remains the sole effective strategy for combating Japanese encephalitis (JE). Both inactivated and live attenuated vaccines exhibit robust immunogenicity. However, the production of these conventional vaccine modalities necessitates extensive
Takele Adugna, Takele Adugna, Takele Adugna, Qingli Niu, Qingli Niu, Guiquan Guan, Guiquan Guan, Junzheng Du, Junzheng Du, Jifei Yang, Jifei Yang, Zhancheng Tian, Zhancheng Tian, Hong Yin, Hong Yin   +14 more
doaj   +1 more source

Safety and immunogenicity following co-administration of Yellow fever vaccine with Tick-borne encephalitis or Japanese encephalitis vaccines: Results from an open label, non-randomized clinical trial. [PDF]

PLoS Negl Trop Dis, 2023
Sandberg JT, Löfling M, Varnaitė R, Emgård J, Al-Tawil N, Lindquist L, Gredmark-Russ S, Klingström J, Loré K, Blom K, Ljunggren HG.   +10 more
europepmc   +1 more source

Safety profile comparison of chimeric live attenuated and Vero cell-derived inactivated Japanese encephalitis vaccines through an active surveillance system in Australia. [PDF]

Hum Vaccin Immunother, 2022
Islam N, Lau C, Leeb A, Mills D, Furuya-Kanamori L.   +4 more
europepmc   +1 more source